Patient Safety Cell

Mission

To safeguard the health of Indian population by ensuring that the benefits of use of medicine and medical devices outweigh the risks associated with its use.

Vision

To improve patient safety and welfare of Indian population by monitoring safety of medicines and medical devices thereby reducing the risk associated with their use.

Pharmacovigilance Programme of India

Pharmacovigilance Programme of India is Government of India's flagship drug safety monitoring programme, which collects, collates and analyses drug-related adverse events and sends recommendations to CDSCO for taking appropriate regulatory actions.

At NIMHANS, the Pharmacovigilance Programme of India (PvPI) is coordinated by Medical Superintendent.

Materiovigilance Programme of India (MvPI)

The Materiovigilance Programme of India (MvPI) systematically collects and analyzes data on adverse events linked to medical devices. It supports regulatory decisions and promotes safe device use nationwide.

MvPI monitors medical device-associated adverse events (MDAEs), raises awareness among healthcare professionals about reporting, evaluates benefit-risk profiles, and delivers independent, evidence-based safety recommendations to all key stakeholders.

At NIMHANS, the Materiovigilance Programme of India (MvPI) is coordinated by the Biomedical Engineering Department. To oversee and manage medical device-associated adverse events (MDAEs), a dedicated Materiovigilance Expert Committee has been established under the leadership of the Medical Superintendent.

Public Notice: Report Adverse Reactions

Patients, healthcare professionals, and the general public are encouraged to report any undesired effects observed with the use of

Drugs
Medical Devices
In-Vitro Diagnostic (IVD) Products
Vaccines

Multiple convenient modalities are available for reporting:

Toll-Free Number - Call 1800 180 3024 to report directly

[Monday to Friday Timing: 9 AM - 5:30 PM, All working days]

ADR PvPI 2.0 Mobile App - Submit reports quickly and easily through the official application available in Google Play Store.

ADRMS Software - An Indigenous Adverse Drug Reactions Monitoring System (ADRMS) by Indian Pharmacopoeia Commission (IPC), Ministry of Health and Family Welfare, Government of India, to ease reporting and monitoring of adverse events (side effects) on patients due to medical products (medicine, vaccine and medical device) for the safety of patients.

Link for the website: https://adrmsipc.in/adrms/index.html

Email Submission - The Adverse Event Reporting Form can be submitted in soft copy via email to
shatrunjay.ipc@gov.in
sindumg@nimhans.ac.in
mvpi.mdmc@nimhans.ac.in

Your participation helps strengthen patient safety and supports continuous monitoring of medicines, devices, and vaccines. Every report matters in ensuring safer healthcare for all.

Note

NIMHANS with reconstituted Materiovigilance Expert Committee